Cargando…
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
The phytocannabinoids of Cannabis sativa L. have, since ancient times, been proposed as a pharmacological alternative for treating various central nervous system (CNS) disorders. Interestingly, cannabinoid receptors (CBRs) are highly expressed in the basal ganglia (BG) circuit of both animals and hu...
Autores principales: | Patricio, Felipe, Morales-Andrade, Alan Axel, Patricio-Martínez, Aleidy, Limón, Ilhuicamina Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770114/ https://www.ncbi.nlm.nih.gov/pubmed/33384602 http://dx.doi.org/10.3389/fphar.2020.595635 |
Ejemplares similares
-
Intrapallidal injection of cannabidiol or a selective GPR55 antagonist decreases motor asymmetry and improves fine motor skills in hemiparkinsonian rats
por: Patricio, Felipe, et al.
Publicado: (2022) -
Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
por: Silva, Jaime, et al.
Publicado: (2022) -
Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors
por: Dávila, Eliud Morales, et al.
Publicado: (2022) -
Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function
por: Limón, Ilhuicamina Daniel, et al.
Publicado: (2021) -
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
por: Campos, Alline C., et al.
Publicado: (2017)